Publicacións (44) Publicacións de Begoña Graña Suárez

2024

  1. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

    JAMA network open, Vol. 7, Núm. 4, pp. e247811

2023

  1. A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

    Biomedicine and Pharmacotherapy, Vol. 159

  2. Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer

    Cancers, Vol. 15, Núm. 17

  3. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)

    Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2627-2633

2022

  1. Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial

    British Journal of Cancer, Vol. 126, Núm. 6, pp. 874-880

  2. Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer

    Clinical and Translational Oncology, Vol. 24, Núm. 6, pp. 1209-1214

2021

  1. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

    BMC Cancer, Vol. 21, Núm. 1

  2. Immunology and immunotherapy in CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 435-453

  3. Recomendaciones de uso adecuado de pruebas y suplementos de vitamina D en población general

    Conselleria de Sanidade

2020

  1. Heat shock protein 90 chaperone regulates the E3 ubiquitin-ligase hakai protein stability

    Cancers, Vol. 12, Núm. 1

  2. Immunology and immunotherapy of colorectal cancer

    Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (Springer), pp. 261-289

  3. Regulation of epithelial-mesenchymal plasticity by the E3 ubiquitin-ligases in cancer

    Cancers, Vol. 12, Núm. 11, pp. 1-24

  4. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)

    Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 193-200

2019

  1. Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

    Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889

  2. SEOM clinical guidelines to primary prevention of cancer (2018)

    Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 106-113

2018

  1. Hakai overexpression effectively induces tumour progression and metastasis in vivo

    Scientific Reports, Vol. 8, Núm. 1

  2. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain

    Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537

2016

  1. Screening for Lynch syndrome among patients with newly diagnosed endometrial cancer: A comprehensive review

    Tumori, Vol. 102, Núm. 6, pp. 548-554

2015

  1. El cáncer hereditario en mujeres

    Arbor: Ciencia, pensamiento y cultura, Núm. 773

  2. SEOM clinical guidelines in Hereditary Breast and ovarian cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 956-961